BiCureSol® is a biocompatible GMP-compliant storage and transport solution that is part of our cell therapy products. It allows cells to be stored at 2-8 °C for a minimum of 72 hours without the need for freezing, with no decrease in cell viability or change in phenotype. It also provides sufficient time to perform all tests according to the product specification before the product is released for clinical use. This also ensures sufficient time for transport to the application site.

BiCureChill is a biocompatible solution for the cryopreservation of stem cells under GMP conditions. BiCureChill allows for long-term storage of cells and enables repeated and immediate administration of cells to the patient without the need for further manipulation such as washing out the cryopreservation solution.

We develop cell-based therapy products for autologous administration in specific clinical indications. Within this effort, we focus on orthopedic, ophthalmologic, neurological and autoimmune diagnoses, and last but not least on wound healing (e.g. burns). In specific projects, we combine the cell component of the product with biocompatible materials based on gels or solid 3D scaffolds. Depending on the target tissues, we develop stem cell-specific culture procedures. Our cell therapy medicinal products are tested in preclinical and clinical studies.

The use of allogeneic stem cells from donors is desirable for some indications (e.g. acute conditions) due to time constraints for the preparation of cell therapy medicinal product or patient‘s condition that does not allow the collection of starting material. In addition, allogeneic cells are preferable and potentially more effective compared to autologous stem cells in some indications due to their characteristics (e.g. source-dependent). Therefore, we are devoting a substantial part of our research to the development of such products including evaluation of different source tissues as well as certain subpopulations of stem cells in adults.

We develop non-cellular pharmaceuticals based on endogenously produced molecules. These products are suitable for augmentation of stem cells effects as well as different biocompatible materials.